Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BEHRING RAPIGNOST TOTAL SCREEN L URINE TEST STRIPS

K-Number: K861255 · 1986-10-03

ApplicantBehring Diagnostics, Inc.
Decision Date1986-10-03
Product CodeJIL
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

BEHRING RAPIGNOST TOTAL SCREEN L URINE TEST STRIPS is the device name listed in this FDA 510(k) record. The listed applicant is Behring Diagnostics, Inc.. It received FDA 510(k) clearance on 1986-10-03 under 510(k) number K861255. The device is classified under product code JIL. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BEHRING RAPIGNOST TOTAL SCREEN L URINE TEST STRIPS?

BEHRING RAPIGNOST TOTAL SCREEN L URINE TEST STRIPS is a medical device that received FDA 510(k) clearance on 1986-10-03. The listed applicant is Behring Diagnostics, Inc.. The 510(k) number is K861255.

When did BEHRING RAPIGNOST TOTAL SCREEN L URINE TEST STRIPS receive FDA 510(k) clearance?

BEHRING RAPIGNOST TOTAL SCREEN L URINE TEST STRIPS received FDA 510(k) clearance on 1986-10-03, under 510(k) number K861255.

Who is the listed applicant for BEHRING RAPIGNOST TOTAL SCREEN L URINE TEST STRIPS?

The FDA 510(k) record lists Behring Diagnostics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BEHRING RAPIGNOST TOTAL SCREEN L URINE TEST STRIPS?

The FDA product code for BEHRING RAPIGNOST TOTAL SCREEN L URINE TEST STRIPS is JIL.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Behring Diagnostics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K973832OPUS HLH CONTROLSK972929N ANTISERUM TO HUMAN ALBUMINK972840N ANTISERUM TO HUMAN TRANSFERRINK973202MODIFICATION OF OPUS FERRITIN TEST SYSTEMK972316OPUS D-DIMERK972116VON WILLEBRAND REAGENT

View all 145 devices →

Related Devices (Code: JIL)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K193514AUTION MAX AX-4060 Urinalysis SystemArkray, Inc.K183432cobas u 601 urinalysis test systemRoche DiagnosticsK173327DIP/U.S. Urine Analysis Test SystemHealthy.Io, Ltd.K180356inui In-Home Urine Analysis Test SystemScanadu, Inc.K181024DUS 2GP Reagent Strips, DUS 5 Reagent Strips, DUS 10 Reagent StripsDFI Co., Ltd.K171521DUS R-50S (Urine Chemistry system)DFI Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑